Shao‐Lai Zhou
- Cancer Research top 1%
- MicroRNA in disease regulation 12
- Hepatology top 1%
- Immunology top 2%
- Immune cells in cancer 6
- Oncology top 2%
- Pancreatic and Hepatic Oncology Research 5
- Molecular Biology top 5%
- Circular RNAs in diseases 9
- RNA modifications and cancer 7
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 15
-
- Cancer Mechanisms and Therapy 6
-
- Ferroptosis and cancer prognosis 5
- Cited by
- Cancer ResearchHepatologyImmunology
- Journals
- Nucleic Acids Research (1 paper)Nature Communications (1 paper)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- ChinaEthiopiaUnited States
In The Last Decade
Shao‐Lai Zhou
57 papers receiving 3.7k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Cancer Research 1.3k
- Hepatology 578
- Immunology 1.2k
- Oncology 1.4k
- Molecular Biology 1.6k
Countries citing papers authored by Shao‐Lai Zhou
This map shows the geographic impact of Shao‐Lai Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shao‐Lai Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shao‐Lai Zhou more than expected).
Fields of papers citing papers by Shao‐Lai Zhou
This network shows the impact of papers produced by Shao‐Lai Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shao‐Lai Zhou. The network helps show where Shao‐Lai Zhou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shao‐Lai Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2024 | 6 | |
| 3 | 2024 | 13 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 11 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 22 | |
| 9 | 2022 | 100 | |
| 10 | 2022 | 22 | |
| 11 | 2021 | 17 | |
| 12 | 2020 | 31 | |
| 13 | 2020 | 20 | |
| 14 | 2020 | 14 | |
| 15 | 2019 | 16 | |
| 16 | 2018 | 204 | |
| 17 | 2018 | 12 | |
| 18 | 2016 | 68 | |
| 19 | 2014 | 88 | |
| 20 | 2009 | 7 |
About Shao‐Lai Zhou
Shao‐Lai Zhou is a scholar working on Cancer Research, Oncology and Hepatology, having authored 58 papers that have together received 3.7k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (15 papers), MicroRNA in disease regulation (12 papers), Circular RNAs in diseases (9 papers), RNA modifications and cancer (7 papers), Cancer Mechanisms and Therapy (6 papers), Immune cells in cancer (6 papers), Ferroptosis and cancer prognosis (5 papers) and Pancreatic and Hepatic Oncology Research (5 papers). The work is most often cited by research in Cancer Research (1.3k citations), Hepatology (578 citations) and Immunology (1.2k citations). Shao‐Lai Zhou has collaborated with scholars based in China, Ethiopia and United States. Frequent co-authors include Jia Fan, Zheng‐Jun Zhou, Jian Zhou, Xiaowu Huang, Zhiqiang Hu, Zhi Dai, Ya Cao, Zheng Wang, Erbao Chen and Chu‐Bin Luo. Their work appears in journals such as Nucleic Acids Research, Nature Communications and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.